nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0656	1	CbGbCtD
Zafirlukast—Encainide—SCN5A—dilated cardiomyopathy	0.0507	0.606	CrCbGaD
Zafirlukast—Vasculitis—Spironolactone—dilated cardiomyopathy	0.0339	0.0451	CcSEcCtD
Zafirlukast—Glyburide—ABCC9—dilated cardiomyopathy	0.033	0.394	CrCbGaD
Zafirlukast—Blister—Furosemide—dilated cardiomyopathy	0.025	0.0332	CcSEcCtD
Zafirlukast—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.0205	0.0273	CcSEcCtD
Zafirlukast—Throat sore—Lisinopril—dilated cardiomyopathy	0.0187	0.0249	CcSEcCtD
Zafirlukast—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.0186	0.0247	CcSEcCtD
Zafirlukast—Vasculitis—Furosemide—dilated cardiomyopathy	0.0184	0.0245	CcSEcCtD
Zafirlukast—Haemoptysis—Lisinopril—dilated cardiomyopathy	0.0182	0.0243	CcSEcCtD
Zafirlukast—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0173	0.023	CcSEcCtD
Zafirlukast—Accidental injury—Lisinopril—dilated cardiomyopathy	0.0153	0.0203	CcSEcCtD
Zafirlukast—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.0148	0.0198	CcSEcCtD
Zafirlukast—Swelling—Furosemide—dilated cardiomyopathy	0.0148	0.0197	CcSEcCtD
Zafirlukast—Vasculitis—Lisinopril—dilated cardiomyopathy	0.0138	0.0184	CcSEcCtD
Zafirlukast—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.0137	0.0182	CcSEcCtD
Zafirlukast—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.0134	0.0178	CcSEcCtD
Zafirlukast—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.0131	0.0174	CcSEcCtD
Zafirlukast—Malaise—Spironolactone—dilated cardiomyopathy	0.013	0.0173	CcSEcCtD
Zafirlukast—Neuropathy—Lisinopril—dilated cardiomyopathy	0.0127	0.0169	CcSEcCtD
Zafirlukast—Discomfort—Spironolactone—dilated cardiomyopathy	0.0122	0.0162	CcSEcCtD
Zafirlukast—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.0116	0.0154	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.0112	0.0149	CcSEcCtD
Zafirlukast—Eosinophilia—Furosemide—dilated cardiomyopathy	0.0112	0.0149	CcSEcCtD
Zafirlukast—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.0109	0.0145	CcSEcCtD
Zafirlukast—Injury—Lisinopril—dilated cardiomyopathy	0.0107	0.0142	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.0102	0.0136	CcSEcCtD
Zafirlukast—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00972	0.0129	CcSEcCtD
Zafirlukast—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00939	0.0125	CcSEcCtD
Zafirlukast—Urticaria—Spironolactone—dilated cardiomyopathy	0.00937	0.0125	CcSEcCtD
Zafirlukast—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00933	0.0124	CcSEcCtD
Zafirlukast—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00869	0.0116	CcSEcCtD
Zafirlukast—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00839	0.0112	CcSEcCtD
Zafirlukast—Pruritus—Spironolactone—dilated cardiomyopathy	0.00835	0.0111	CcSEcCtD
Zafirlukast—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00807	0.0107	CcSEcCtD
Zafirlukast—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00792	0.0105	CcSEcCtD
Zafirlukast—Dizziness—Spironolactone—dilated cardiomyopathy	0.0078	0.0104	CcSEcCtD
Zafirlukast—Vomiting—Spironolactone—dilated cardiomyopathy	0.0075	0.00998	CcSEcCtD
Zafirlukast—Rash—Spironolactone—dilated cardiomyopathy	0.00744	0.0099	CcSEcCtD
Zafirlukast—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00743	0.00989	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.0074	0.00985	CcSEcCtD
Zafirlukast—Headache—Spironolactone—dilated cardiomyopathy	0.00739	0.00983	CcSEcCtD
Zafirlukast—Jaundice—Lisinopril—dilated cardiomyopathy	0.00736	0.00979	CcSEcCtD
Zafirlukast—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00709	0.00943	CcSEcCtD
Zafirlukast—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00705	0.00938	CcSEcCtD
Zafirlukast—Nausea—Spironolactone—dilated cardiomyopathy	0.00701	0.00932	CcSEcCtD
Zafirlukast—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00678	0.00902	CcSEcCtD
Zafirlukast—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00629	0.00836	CcSEcCtD
Zafirlukast—Back pain—Lisinopril—dilated cardiomyopathy	0.00571	0.00759	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00554	0.00737	CcSEcCtD
Zafirlukast—Fatigue—Furosemide—dilated cardiomyopathy	0.00554	0.00736	CcSEcCtD
Zafirlukast—Pain—Furosemide—dilated cardiomyopathy	0.00549	0.0073	CcSEcCtD
Zafirlukast—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00548	0.00729	CcSEcCtD
Zafirlukast—Angioedema—Lisinopril—dilated cardiomyopathy	0.00539	0.00717	CcSEcCtD
Zafirlukast—Malaise—Lisinopril—dilated cardiomyopathy	0.00532	0.00708	CcSEcCtD
Zafirlukast—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00529	0.00704	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00525	0.00698	CcSEcCtD
Zafirlukast—Urticaria—Furosemide—dilated cardiomyopathy	0.0051	0.00678	CcSEcCtD
Zafirlukast—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00508	0.00675	CcSEcCtD
Zafirlukast—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00508	0.00675	CcSEcCtD
Zafirlukast—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00502	0.00668	CcSEcCtD
Zafirlukast—Myalgia—Lisinopril—dilated cardiomyopathy	0.00502	0.00668	CcSEcCtD
Zafirlukast—Discomfort—Lisinopril—dilated cardiomyopathy	0.00496	0.0066	CcSEcCtD
Zafirlukast—Oedema—Lisinopril—dilated cardiomyopathy	0.00482	0.00641	CcSEcCtD
Zafirlukast—Infection—Lisinopril—dilated cardiomyopathy	0.00479	0.00637	CcSEcCtD
Zafirlukast—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00473	0.00629	CcSEcCtD
Zafirlukast—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00472	0.00627	CcSEcCtD
Zafirlukast—Asthenia—Furosemide—dilated cardiomyopathy	0.00461	0.00613	CcSEcCtD
Zafirlukast—Pruritus—Furosemide—dilated cardiomyopathy	0.00454	0.00604	CcSEcCtD
Zafirlukast—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00439	0.00584	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00439	0.00584	CcSEcCtD
Zafirlukast—Insomnia—Lisinopril—dilated cardiomyopathy	0.00436	0.0058	CcSEcCtD
Zafirlukast—Dizziness—Furosemide—dilated cardiomyopathy	0.00425	0.00565	CcSEcCtD
Zafirlukast—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00424	0.00564	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00416	0.00553	CcSEcCtD
Zafirlukast—Fatigue—Lisinopril—dilated cardiomyopathy	0.00415	0.00552	CcSEcCtD
Zafirlukast—Pain—Lisinopril—dilated cardiomyopathy	0.00412	0.00548	CcSEcCtD
Zafirlukast—Vomiting—Furosemide—dilated cardiomyopathy	0.00408	0.00543	CcSEcCtD
Zafirlukast—Rash—Furosemide—dilated cardiomyopathy	0.00405	0.00538	CcSEcCtD
Zafirlukast—Dermatitis—Furosemide—dilated cardiomyopathy	0.00404	0.00538	CcSEcCtD
Zafirlukast—Headache—Furosemide—dilated cardiomyopathy	0.00402	0.00535	CcSEcCtD
Zafirlukast—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00397	0.00528	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00394	0.00524	CcSEcCtD
Zafirlukast—Urticaria—Lisinopril—dilated cardiomyopathy	0.00383	0.00509	CcSEcCtD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00382	0.0386	CbGpPWpGaD
Zafirlukast—Nausea—Furosemide—dilated cardiomyopathy	0.00381	0.00507	CcSEcCtD
Zafirlukast—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00381	0.00507	CcSEcCtD
Zafirlukast—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00381	0.00507	CcSEcCtD
Zafirlukast—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00355	0.00472	CcSEcCtD
Zafirlukast—Asthenia—Lisinopril—dilated cardiomyopathy	0.00346	0.0046	CcSEcCtD
Zafirlukast—Pruritus—Lisinopril—dilated cardiomyopathy	0.00341	0.00453	CcSEcCtD
Zafirlukast—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.0033	0.00438	CcSEcCtD
Zafirlukast—Dizziness—Lisinopril—dilated cardiomyopathy	0.00319	0.00424	CcSEcCtD
Zafirlukast—Vomiting—Lisinopril—dilated cardiomyopathy	0.00306	0.00407	CcSEcCtD
Zafirlukast—Rash—Lisinopril—dilated cardiomyopathy	0.00304	0.00404	CcSEcCtD
Zafirlukast—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00303	0.00404	CcSEcCtD
Zafirlukast—Headache—Lisinopril—dilated cardiomyopathy	0.00302	0.00401	CcSEcCtD
Zafirlukast—Nausea—Lisinopril—dilated cardiomyopathy	0.00286	0.00381	CcSEcCtD
Zafirlukast—CYSLTR2—Endothelins—RAC1—dilated cardiomyopathy	0.00281	0.0283	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00265	0.0267	CbGpPWpGaD
Zafirlukast—CYSLTR1—Endothelins—RAC1—dilated cardiomyopathy	0.00194	0.0196	CbGpPWpGaD
Zafirlukast—CYSLTR2—Endothelins—RAF1—dilated cardiomyopathy	0.00186	0.0188	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.0016	0.0162	CbGpPWpGaD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.0016	0.0161	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00149	0.0151	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00144	0.0146	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00143	0.0144	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00137	0.0139	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00137	0.0139	CbGpPWpGaD
Zafirlukast—CYSLTR1—Endothelins—RAF1—dilated cardiomyopathy	0.00129	0.013	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00128	0.0129	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00124	0.0125	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00123	0.0125	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00117	0.0118	CbGpPWpGaD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00112	0.0113	CbGpPWpGaD
Zafirlukast—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00111	0.0113	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00111	0.0112	CbGpPWpGaD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00111	0.0112	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00106	0.0107	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00105	0.0106	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00105	0.0106	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00103	0.0104	CbGpPWpGaD
Zafirlukast—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00102	0.0103	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.001	0.0101	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.001	0.0101	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.001	0.0101	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000989	0.00999	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000973	0.00982	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000952	0.00962	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000952	0.00962	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000942	0.00951	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000885	0.00894	CbGpPWpGaD
Zafirlukast—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000868	0.00877	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000857	0.00866	CbGpPWpGaD
Zafirlukast—PTGS1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000857	0.00865	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000855	0.00863	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000811	0.00819	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000804	0.00812	CbGpPWpGaD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000778	0.00786	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000763	0.00771	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000743	0.00751	CbGpPWpGaD
Zafirlukast—PTGS1—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.000738	0.00746	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000732	0.0074	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000725	0.00732	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000725	0.00732	CbGpPWpGaD
Zafirlukast—CYP2E1—Vitamin A and Carotenoid Metabolism—CD36—dilated cardiomyopathy	0.000703	0.0071	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000697	0.00704	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000696	0.00703	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000695	0.00702	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000674	0.00681	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000653	0.00659	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000591	0.00597	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000591	0.00597	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000571	0.00577	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000566	0.00572	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000558	0.00563	CbGpPWpGaD
Zafirlukast—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000553	0.00559	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00055	0.00555	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000545	0.0055	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000537	0.00542	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000537	0.00542	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000532	0.00538	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00053	0.00535	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000529	0.00534	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000515	0.0052	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000499	0.00504	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000498	0.00503	CbGpPWpGaD
Zafirlukast—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000494	0.00499	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000483	0.00488	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000483	0.00488	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000478	0.00483	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000455	0.00459	CbGpPWpGaD
Zafirlukast—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00045	0.00455	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000431	0.00436	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000413	0.00417	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00041	0.00414	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00041	0.00414	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000401	0.00405	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000392	0.00396	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000392	0.00396	CbGpPWpGaD
Zafirlukast—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000385	0.00389	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000381	0.00385	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000374	0.00378	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000372	0.00376	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000372	0.00376	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000369	0.00373	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000364	0.00367	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000364	0.00367	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000357	0.00361	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000346	0.00349	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000342	0.00346	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000338	0.00341	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000335	0.00338	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000335	0.00338	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000331	0.00334	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000322	0.00325	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00032	0.00323	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000317	0.0032	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000317	0.0032	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000315	0.00318	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000306	0.00309	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000304	0.00307	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000299	0.00302	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000295	0.00298	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000291	0.00293	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000287	0.0029	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000286	0.00289	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000286	0.00288	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000279	0.00281	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000271	0.00274	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000262	0.00265	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.00025	0.00253	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000248	0.0025	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000246	0.00248	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000244	0.00246	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000238	0.0024	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000236	0.00238	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000232	0.00234	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000231	0.00234	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	0.000231	0.00233	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000224	0.00226	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	0.000222	0.00224	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000222	0.00224	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00022	0.00222	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00022	0.00222	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000217	0.00219	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000211	0.00213	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	0.000209	0.00211	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000204	0.00206	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000202	0.00204	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000201	0.00203	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	0.000201	0.00203	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000199	0.00201	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000198	0.002	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00018	0.00181	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000176	0.00178	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000172	0.00173	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000172	0.00173	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—AGT—dilated cardiomyopathy	0.000172	0.00173	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000169	0.00171	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	0.000166	0.00168	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000163	0.00165	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000163	0.00165	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00016	0.00162	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	0.000152	0.00154	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	0.00015	0.00151	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	0.000143	0.00145	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.00014	0.00141	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000138	0.0014	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000138	0.00139	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	0.000136	0.00137	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	0.00013	0.00131	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	0.000128	0.00129	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000125	0.00126	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000124	0.00126	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000124	0.00125	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000122	0.00124	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000119	0.0012	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000119	0.0012	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000119	0.0012	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	0.000118	0.00119	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	0.000117	0.00118	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	0.000116	0.00117	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000107	0.00108	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	0.000106	0.00107	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000106	0.00107	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	0.000106	0.00107	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	9.97e-05	0.00101	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.58e-05	0.000968	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	9.02e-05	0.000911	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—RAF1—dilated cardiomyopathy	8.26e-05	0.000834	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	8.18e-05	0.000827	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—EGFR—dilated cardiomyopathy	8.17e-05	0.000825	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.91e-05	0.000799	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.7e-05	0.000778	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	7.69e-05	0.000777	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.37e-05	0.000745	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.06e-05	0.000713	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	6.96e-05	0.000703	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.93e-05	0.0007	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.87e-05	0.000694	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.44e-05	0.00065	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.27e-05	0.000633	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.19e-05	0.000625	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	5.68e-05	0.000573	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—EGFR—dilated cardiomyopathy	5.66e-05	0.000572	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.64e-05	0.00057	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CD36—dilated cardiomyopathy	5.53e-05	0.000558	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.5e-05	0.000555	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	5.45e-05	0.000551	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.36e-05	0.000541	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CD36—dilated cardiomyopathy	5.31e-05	0.000536	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AGT—dilated cardiomyopathy	4.98e-05	0.000503	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.82e-05	0.000487	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AGT—dilated cardiomyopathy	4.78e-05	0.000483	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	4.07e-05	0.000412	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	3.97e-05	0.000401	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	3.57e-05	0.000361	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	3.52e-05	0.000356	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	3.43e-05	0.000346	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	3.14e-05	0.000317	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	3.09e-05	0.000312	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	3.06e-05	0.000309	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	2.89e-05	0.000292	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	2.87e-05	0.000289	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	2.82e-05	0.000284	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	2.79e-05	0.000282	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	2.76e-05	0.000278	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	2.54e-05	0.000256	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	2.51e-05	0.000254	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	2.45e-05	0.000247	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	2.39e-05	0.000241	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	2.15e-05	0.000217	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.89e-05	0.000191	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.84e-05	0.000186	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.66e-05	0.000167	CbGpPWpGaD
